These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 5232847)
21. [Primary disorders of serum lipoproteins in children]. Tamir I Harefuah; 1971 May; 80(9):507-9. PubMed ID: 5113992 [No Abstract] [Full Text] [Related]
22. [Diagnosis of sphingolipidosis in young children. Current methods and future prospects]. Gigonnet JM; Juif JG Presse Med (1893); 1970 Nov; 78(50):2249-53. PubMed ID: 5530713 [No Abstract] [Full Text] [Related]
28. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]. Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086 [TBL] [Abstract][Full Text] [Related]
29. [Combined use of tandem mass spectrometry with urine gas chromatography/mass spectrometry is useful for diagnosis of inborn errors of metabolism in children]. Xie LJ; Zhu JX; Zhu XD; Li HJ; Han LS; Gu XF Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):31-4. PubMed ID: 18289467 [TBL] [Abstract][Full Text] [Related]
30. The critically ill child: acute metabolic disease in infancy and early childhood. O'Brien D; Goodman SI Pediatrics; 1970 Oct; 46(4):620-6. PubMed ID: 5503697 [No Abstract] [Full Text] [Related]
31. Detection of Fabry hemizygotes and heterozygotes by measurement of -galactosidase in urine. Rietra PJ; Tager JM; de Groot WP Clin Chim Acta; 1972 Aug; 40(1):229-35. PubMed ID: 5056633 [No Abstract] [Full Text] [Related]
32. [Nature of non-specific inhibitors of streptolysin O and the usefulness of their determination in pediatric clinical practice]. Wańkowicz-Ponurska R Pediatr Pol; 1971 Feb; 46(2):165-9. PubMed ID: 5553860 [No Abstract] [Full Text] [Related]
34. [Protides of biological fluids. Report on the 19th colloquium Brügge-Belgium]. Schwandt E Fortschr Med; 1971 Sep; 89(26):8-13. PubMed ID: 5154199 [No Abstract] [Full Text] [Related]
35. A review of newborn screening in the era of tandem mass spectrometry: what's new for the pediatric neurologist? Copeland S Semin Pediatr Neurol; 2008 Sep; 15(3):110-6. PubMed ID: 18708000 [TBL] [Abstract][Full Text] [Related]
36. [Neonatal screening for metabolic diseases: need for efficacy studies]. Bosch AM; van Spronsen FJ Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2366-7; author reply 2367. PubMed ID: 19031509 [No Abstract] [Full Text] [Related]
37. [A new disease caused by accumulation of glycolipids. (Ceramide tetrahexosides)]. Durand P; Philippart M; Borrone C; Della Cella G; Bugiani O Minerva Pediatr; 1967 Dec; 19(49):2187-96. PubMed ID: 5607240 [No Abstract] [Full Text] [Related]
39. Evaluation of lipid disorders by lipoprotein electrophoresis. Wilson WB J Miss State Med Assoc; 1971 Jun; 12(6):287-96. PubMed ID: 5132294 [No Abstract] [Full Text] [Related]
40. [Proceedings: Genetic aspects of lipid metabolism disorders]. Fuhrmann W MMW Munch Med Wochenschr; 1974 May; 116(22):1110-1. PubMed ID: 4211592 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]